New sustainable treatment strategies for infectious diseases
During the last 30 years only 2 new classes of antibiotics have been introduced to the market and today there are only 10-fold candidates in late clinical development.
In order to meet the global treat with resistant bacteria, we need to change out mindset regarding the treatment of infectious diseases. We need a large battery of available treatments that can be used in a smart, strategic and sustainable way. We also need treatments effective against multidrug resistant strains. An antimicrobial compounds with new mechanism of action is one part of the puzzle.
Within RISE we work with